Source: American Banking and Market News

ANI: ANI Pharmaceuticals (NASDAQ:ANIP) Upgraded at StockNews.com

ANI Pharmaceuticals (NASDAQ:ANIP - Get Free Report) was upgraded by equities research analysts at StockNews.com from a "sell" rating to a "hold" rating in a note issued to investors on Wednesday. A number of other research analysts have also recently issued reports on the stock. Jefferies Financial Group initiated coverage on shares of ANI Pharmaceuticals [...]

Read full article »
Annual Revenue
$500M-1.0B
Employees
500-1.0K
Nikhil Lalwani's photo - President & CEO of ANI

President & CEO

Nikhil Lalwani

CEO Approval Rating

84/100

Read more